inovmedИнновационная медицина КубаниInnovative Medicine of Kuban2541-9897Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 110.35401/2500-0268-2020-19-3-77-85inovmed-298Research ArticleОБЗОРЫREVIEWSОртостатическая гипотония. Часть 2: диагностика и лечениеOrthostatic hypotension. Part 2: diagnosis and treatmenthttps://orcid.org/0000-0002-4866-0345ГоловинаГ. А.GolovinaG. A.

Головина Галина Александровна, к. м. н., врачкардиолог, кардиологическое отделение № 4

350086, Краснодар, ул. 1 Мая, 167

Galina A. Golovina, Cand. of Sci. (Med.), Cardiologist, Cardiology Department no. 4

ul. 1 Maya, 167, Krasnodar, 350086

ggolovina.70@mail.ruhttps://orcid.org/0000-0002-6984-5744ЖаданО. Н.ZhadanO. N.

Жадан Ольга Николаевна, врач-невролог, заведующая отделением медицинской реабилитации для пациентов с нарушением функции центральной нервной системы

Краснодар

Olga N. Zhadan, Neurologist, Head of the Department of Medical Rehabilitation of Patients with Impaired Function of the Central Nervous System

Krasnodar

https://orcid.org/0000-0003-3596-4275ЗаргарянК. А.ZargaryanK. A.

Заргарян Карина Александровна, врач-кардиолог, кардиологическое отделение № 4

Краснодар

Karina A. Zargaryan, Cardiologist, Cardiology Department #4

Krasnodar

https://orcid.org/0000-0002-2015-3907КравченкоО. А.KravchenkoO. A.

Кравченко Олеся Анатольевна, врач-кардиолог, кардиологическое отделение № 4

Краснодар

Olesya A. Kravchenko, Cardiologist, Cardiology Department no. 4

Krasnodar

https://orcid.org/0000-0001-9208-3867ТрипольскаяН. Е.TripolskayaN. Ye.

Трипольская Наталья Евгеньевна, врач-кардиолог, кардиологическое отделение № 4

Краснодар

Natalya Ye. Tripolskaya, Cardiologist, Cardiology Department no. 4

Krasnodar

Научно-исследовательский институт – Краевая клиническая больница № 1 им. проф. С.В. Очаповского Министерства здравоохранения Краснодарского краяРоссияScientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1Russian Federation202030092020037785Copyright © Головина Г.А., Жадан О.Н., Заргарян К.А., Кравченко О.А., Трипольская Н.Е., 20202020Головина Г.А., Жадан О.Н., Заргарян К.А., Кравченко О.А., Трипольская Н.Е.Golovina G.A., Zhadan O.N., Zargaryan K.A., Kravchenko O.A., Tripolskaya N.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.innovmedkub.ru/jour/article/view/298

Ортостатическая гипотония (ОГ) чаще всего протекает бессимптомно, в связи с чем выявить ее возможно только при проведении ортостатических проб. Важно определить этиологию ОГ в каждом отдельном случае, так как лечение заболевания, вызвавшего ОГ, позволит улучшить прогноз здоровья пациента. Целью терапии ОГ выступает улучшение функционального состояния больного, уменьшение симптомов и снижение риска падений и обмороков, а не достижение определенных показателей артериального давления. Информированность врачей различных специальностей о способах диагностики ОГ, медикаментозных и немедикаментозных методах ее лечения позволит улучшить качество жизни пациентов, для которых характерно это состояние. Первая часть обзорного исследования, посвященного ортостатической гипотонии, опубликована в №4 журнала «Инновационная медицина Кубани» за 2018 г.

Due to its asymptomatic nature, orthostatic hypotension can be diagnosed only by means of orthostatic challenge. One should try to define the causes of orthostatic hypotension in every single case because treating illness that lead to orthostatic hypotension will improve patient’s health outcomes. The main target for therapy should be improving patient’s functional status, reducing orthostatic symptoms as well as risk for falls and syncopes, but not maintaining arterial blood pressure within certain limits. Doctors need to be aware of the methods for diagnosing the orthostatic hypotension to provide patients with the better quality of life. The first part of the systematic review was published in the Innovative Medicine of Kuban, no. 4, 2018.

ортостатическая гипотонияобморокортостатическая пробаorthostatic hypotensionsyncopeorthostatic challengeReferencesBrignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope – update 2004. Europace. 2004;6:467–537. PMID: 15519256. doi:10.1016/j.eupc.2004.08.008Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope – update 2004. Europace. 2004;6:467–537. PMID: 15519256. doi:10.1016/j.eupc.2004.08.008Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–71. PMID: 19713422. PMCID: PMC3295536. doi:10.1093/eurheartj/ehp298Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–71. PMID: 19713422. PMCID: PMC3295536. doi:10.1093/eurheartj/ehp298Shen W-K, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e60–e122. PMID: 28280231. doi:10.1161/CIR.0000000000000499Shen W-K, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e60–e122. PMID: 28280231. doi:10.1161/CIR.0000000000000499Brignole M, Moya A, de Lange FJ, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948. PMID: 29562304. doi:10.1093/eurheartj/ehy037Brignole M, Moya A, de Lange FJ, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948. PMID: 29562304. doi:10.1093/eurheartj/ehy037Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72. PMID: 21431947. doi:10.1007/s10286-011-0119-5Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72. PMID: 21431947. doi:10.1007/s10286-011-0119-5Shibao C, Lipsitz LA, Biaggioni I. ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich). 2013;15:147–53. PMID: 23458585. doi:10.1111/jch.12062Shibao C, Lipsitz LA, Biaggioni I. ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich). 2013;15:147–153. PMID: 23458585. doi:10.1111/jch.12062Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848–60. PMID: 26271068. doi:10.1016/j.jacc.2015.06.1084Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848–60. PMID: 26271068. doi:10.1016/j.jacc.2015.06.1084Goldstein DS, Sharabi Ye. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119:139–46. PMID: 19124673. PMCID: PMC4182314. doi:10.1161/CIRCULATIONAHA.108.805887Goldstein DS, Sharabi Ye. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119:139–46. PMID: 19124673. PMCID: PMC4182314. doi:10.1161/CIRCULATIONAHA.108.805887Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 8-й выпуск. Сахарный диабет. 2017;20(1S):1–112. doi:10.14341/DM221S1Dedov II, Shestakova MV, Mayorov AYu (eds). Standards of specialized diabetes care. 8th ed. Diabetes mellitus. 2017;20(1S):1–112. (In Russ.). doi:10.14341/DM221S1Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159–219. PMID: 23771844. doi:10.1093/eurheartj/eht151Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159–219. PMID: 23771844. doi:10.1093/eurheartj/eht151Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. PMID: 30165516. doi:10.1093/eurheartj/ehy339Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. PMID: 30165516. doi:10.1093/eurheartj/ehy339Valbusa F, Labat C, Salvi P, et al. Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens. 2012;30:53–60. PMID: 22080223. doi:10.1097/HJH.0b013e32834d3d73Valbusa F, Labat C, Salvi P, et al. Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens. 2012;30:53–60. PMID: 22080223. doi:10.1097/HJH.0b013e32834d3d73Romero-Ortuno R, O’Connell MD, Finucane C, Soraghan C, Fan ChW, Kenny RA. Insights into the clinical management of the syndrome of supine hypertension – orthostatic hypotension (SH-OH): the Irish Longitudinal Study on Ageing (TILDA). BMC Geriatr. 2013;13:73. PMID: 23855394. PMCID: PMC3716968. doi:10.1186/1471-2318-13-73Romero-Ortuno R, O’Connell MD, Finucane C, Soraghan C, Fan ChW, Kenny RA. Insights into the clinical management of the syndrome of supine hypertension – orthostatic hypotension (SH-OH): the Irish Longitudinal Study on Ageing (TILDA). BMC Geriatr. 2013;13:73. PMID: 23855394. PMCID: PMC3716968. doi:10.1186/1471-2318-13-73Canney M, O’Connell MD, Murphy CM, et al. Single agent antihypertensive therapy and orthostatic blood pressure behaviour in older adults using beat-to-beat measurements: the Irish Longitudinal Study on Ageing. PLoS One. 2016;11:e0146156. PMID: 26730962. PMCID: PMC4701419. doi:10.1371/journal.pone.0146156Canney M, O’Connell MD, Murphy CM, et al. Single agent antihypertensive therapy and orthostatic blood pressure behaviour in older adults using beat-to-beat measurements: the Irish Longitudinal Study on Ageing. PLoS One. 2016;11:e0146156. PMID: 26730962. PMCID: PMC4701419. doi:10.1371/journal.pone.0146156Fogari R, Zoppi A, Mugellini A, et al. Efficacy and safety of two treatment combinations of hypertension in very elderly patients. Arch Gerontol Geriatr. 2009;48:401–5. PMID: 18457886. doi:10.1016/j.archger.2008.03.012Fogari R, Zoppi A, Mugellini A, et al. Efficacy and safety of two treatment combinations of hypertension in very elderly patients. Arch Gerontol Geriatr. 2009;48:401–5. PMID: 18457886. doi:10.1016/j.archger.2008.03.012Di Stefano C, Milazzo V, Totaro S, et al. Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic. J Hum Hypertens. 2015;29:599–603. PMID: 25631221. doi:10.1038/jhh.2014.130Di Stefano C, Milazzo V, Totaro S, et al. Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic. J Hum Hypertens. 2015;29:599–603. PMID: 25631221. doi:10.1038/jhh.2014.130Kamaruzzaman Sh, Watt H, Carson C, Ebrahim Sh. The association between orthostatic hypotension and medication use in the British Women’s Heart and Health Study. Age Ageing. 2010;39:51–6. PMID: 19897539. doi:10.1093/ageing/afp192Kamaruzzaman Sh, Watt H, Carson C, Ebrahim Sh. The association between orthostatic hypotension and medication use in the British Women’s Heart and Health Study. Age Ageing. 2010;39:51–6. PMID: 19897539. doi:10.1093/ageing/afp192Heseltine D, Bramble MG. Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly. Curr Med Res Opin. 1988;11:232–5. PMID: 3215040. doi:10.1185/03007998809114241Heseltine D, Bramble MG. Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly. Curr Med Res Opin. 1988;11:232–5. PMID: 3215040. doi:10.1185/03007998809114241Bird ST, Delaney JA, Brophy JM, Etminan M, Skeldon SC, Hartzema AG. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40–85 years in the United States: risk window analyses using between and within patient methodology. BMJ. 2013;347:f6320. PMID: 24192967. PMCID: PMC3817852. doi:10.1136/bmj.f6320Bird ST, Delaney JA, Brophy JM, Etminan M, Skeldon SC, Hartzema AG. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40–85 years in the United States: risk window analyses using between and within patient methodology. BMJ. 2013;347:f6320. PMID: 24192967. PMCID: PMC3817852. doi:10.1136/bmj.f6320Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952–60. PMID: 19933955. doi:10.1001/archinternmed.2009.357Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952–60. PMID: 19933955. doi:10.1001/archinternmed.2009.357de Bruïne ES, Reijnierse EM, Trappenburg MC, et al. Standing up slowly antagonises initial blood pressure decrease in older adults with orthostatic hypotension. Gerontology. 2017;63:137–43. PMID: 27756060. doi:10.1159/000450642de Bruïne ES, Reijnierse EM, Trappenburg MC, et al. Standing up slowly antagonises initial blood pressure decrease in older adults with orthostatic hypotension. Gerontology. 2017;63:137–43. PMID: 27756060. doi:10.1159/000450642Wieling W, van Dijk N, Thijs RD, de Lange FJ, Krediet CT, Halliwill JR. Physical countermeasures to increase orthostatic tolerance. J Intern Med. 2015;277:69–82. PMID: 24697914. doi:10.1111/joim.12249Wieling W, van Dijk N, Thijs RD, de Lange FJ, Krediet CT, Halliwill JR. Physical countermeasures to increase orthostatic tolerance. J Intern Med. 2015;277:69–82. PMID: 24697914. doi:10.1111/joim.12249Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans: a sympathetic reflex? Circulation. 2000;101:504–9. PMID: 10662747. doi:10.1161/01.cir.101.5.504Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans: a sympathetic reflex? Circulation. 2000;101:504–9. PMID: 10662747. doi:10.1161/01.cir.101.5.504Jordan J. Acute effect of water on blood pressure. What do we know? Clin Auton Res. 2002;12:250–5. PMID: 12357278. doi:10.1007/s10286-002-0055-5Jordan J. Acute effect of water on blood pressure. What do we know? Clin Auton Res. 2002;12:250–5. PMID: 12357278. doi:10.1007/s10286-002-0055-5Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized singleblind controlled study. J Am Coll Cardiol. 2006;48:1425–32. PMID: 17010806. doi:10.1016/j.jacc.2006.06.052Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol. 2006;48:1425–32. PMID: 17010806. doi:10.1016/j.jacc.2006.06.052Figueroa JJ, Basford JR, Low PhA. Preventing and treating orthostatic hypotension: a easy as A, B, C. Cleve Clin J Med. 2010;77:298–306. PMID: 20439562. doi:10.3949/ccjm.77a.09118Figueroa JJ, Basford JR, Low PhA. Preventing and treating orthostatic hypotension: a easy as A, B, C. Cleve Clin J Med. 2010;77:298–306. PMID: 20439562. doi:10.3949/ccjm.77a.09118Ten Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232:139–45. PMID: 1506810. doi:10.1111/j.1365-2796.1992.tb00563.xTen Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232:139–45. PMID: 1506810. doi:10.1111/j.1365-2796.1992.tb00563.xOmboni S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (Lond). 2001;101:609–18. PMID: 11724647.Omboni S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (Lond). 2001;101:609–18. PMID: 11724647.Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018;91:e652–e656. PMID: 30006412. PMCID: PMC6105042. doi:10.1212/WNL.0000000000005994Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018;91:e652–e656. PMID: 30006412. PMCID: PMC6105042. doi:10.1212/WNL.0000000000005994Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95:38–48. PMID: 7687093. doi:10.1016/0002-9343(93)90230-mJankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95:38–48. PMID: 7687093. doi:10.1016/0002-9343(93)90230-mLow PhA, Gilden JL, Freeman R, Sheng K-N, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study [published correction appears in JAMA. 1997;278:388. doi: 10.1001/jama.1997.03550050050031]. JAMA. 1997;277:1046–51. PMID: 9091692. doi:10.1001/jama.1997.03540370036033Low PhA, Gilden JL, Freeman R, Sheng K-N, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study [published correction appears in JAMA. 1997;278:388. doi: 10.1001/jama.1997.03550050050031]. JAMA. 1997;277:1046–51. PMID: 9091692. doi:10.1001/jama.1997.03540370036033Wright RA, Kaufmann HC, Perera R, et al. A doubleblind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51:120–4. PMID: 9674789. doi:10.1212/wnl.51.1.120Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51:120–4. PMID: 9674789. doi:10.1212/wnl.51.1.120van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35–42. PMID: 1075642. doi:10.1007/BF02291388van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35–42. PMID: 1075642. doi:10.1007/BF02291388Axelrod FB, Goldberg JD, Rolnitzky L, et al. Fludrocortisone in patients with familial dysautonomia – assessing effect on clinical parameters and gene expression. Clin Auton Res. 2005;15:284–91. PMID: 16032383. doi:10.1007/s10286-005-0288-1Axelrod FB, Goldberg JD, Rolnitzky L, et al. Fludrocortisone in patients with familial dysautonomia – assessing effect on clinical parameters and gene expression. Clin Auton Res. 2005;15:284–91. PMID: 16032383. doi:10.1007/s10286-005-0288-1Finke J, Sagemüller I. Fludrocortisone in the treatment of orthostatic hypotension: ophthalmodynamography during standing (author’s transl). Dtsch Med Wochenschr. 1975;100:1790–2. PMID: 1098888. doi:10.1055/s-0028-1106461Finke J, Sagemüller I. Fludrocortisone in the treatment of orthostatic hypotension: ophthalmodynamography during standing (author’s transl). Dtsch Med Wochenschr. 1975;100:1790–2. PMID: 1098888. doi:10.1055/s-0028-1106461Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83:328– 35. PMID: 24944260. PMCID: PMC4115605. doi:10.1212/WNL.0000000000000615Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83:328–35. PMID: 24944260. PMCID: PMC4115605. doi:10.1212/WNL.0000000000000615Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson’s disease (nOH306B). Mov Disord. 2015;30:646–54. PMID: 25487613. doi:10.1002/mds.26086Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson’s disease (nOH306B). Mov Disord. 2015;30:646–54. PMID: 25487613. doi:10.1002/mds.26086Biaggioni I, Freeman R, Mathias CJ, Low Ph, Hewitt LA, Kaufmann H. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65:101–7. PMID: 25350981. PMCID: PMC4354798. doi:10.1161/HYPERTENSIONAHA.114.04035Biaggioni I, Freeman R, Mathias CJ, Low Ph, Hewitt L.A., Kaufmann H. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65:101–7. PMID: 25350981. PMCID: PMC4354798. doi:10.1161/HYPERTENSIONAHA.114.04035Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson’s disease (NOH306A). J Parkinsons Dis. 2014;4:57–65. PMID: 24326693. doi:10.3233/JPD-130259Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson’s disease (NOH306A). J Parkinsons Dis. 2014;4:57–65. PMID: 24326693. doi:10.3233/JPD-130259Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ. Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis. 2016;6:751–759. PMID: 27636856. doi:10.3233/JPD-160860Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ. Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis. 2016;6:751–759. PMID: 27636856. doi:10.3233/JPD-160860Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294–8. PMID: 12933939. PMCID: PMC1738643. doi:10.1136/jnnp.74.9.1294Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294–8. PMID: 12933939. PMCID: PMC1738643. doi:10.1136/jnnp.74.9.1294Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63:513–8. PMID: 16476804. doi:10.1001/archneur.63.4.noc50340Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63:513–8. PMID: 16476804. doi:10.1001/archneur.63.4.noc50340Schreglmann SR, Büchele F, Sommerauer M, et al. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson’s disease – a randomized controlled trial. Eur J Neurol. 2017;24:545–51. PMID: 28224720. doi:10.1111/ene.13260Schreglmann SR, Büchele F, Sommerauer M, et al. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson’s disease – a randomized controlled trial. Eur J Neurol. 2017;24:545–51. PMID: 28224720. doi:10.1111/ene.13260Shibao C, Okamoto LE, Gamboa A, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56:847–51. PMID: 20837887. PMCID: PMC2959129. doi:10.1161/HYPERTENSIONAHA.110.154898Shibao C, Okamoto LE, Gamboa A, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56:847–51. PMID: 20837887. PMCID: PMC2959129. doi:10.1161/HYPERTENSIONAHA.110.154898Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567–82. PMID: 28050656. PMCID: PMC5533816. doi:10.1007/s00415-016-8375-xGibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567–82. PMID: 28050656. PMCID: PMC5533816. doi:10.1007/s00415-016-8375-xRamirez CE, Okamoto LE, Arnold AC, et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014;64:1235– 40. PMID: 25185131. PMCID: PMC4231172. doi:10.1161/HYPERTENSIONAHA.114.04225Ramirez CE, Okamoto LE, Arnold AC, et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014;64:1235–40. PMID: 25185131. PMCID: PMC4231172. doi:10.1161/HYPERTENSIONAHA.114.04225Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure. Hypertension. 2012;59:650–6. PMID: 22311903. PMCID: PMC3312003. doi:10.1161/HYPERTENSIONAHA.111.184812Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure. Hypertension. 2012;59:650–6. PMID: 22311903. PMCID: PMC3312003. doi:10.1161/HYPERTENSIONAHA.111.184812Sakakibara R, Matsuda Sh, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res. 2003;13:106–8. PMID: 12720096. doi:10.1007/s10286-003-0052-3Sakakibara R, Matsuda Sh, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res. 2003;13:106–8. PMID: 12720096. doi:10.1007/s10286-003-0052-3Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an α-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54–61. PMID: 17515447. doi:10.1161/HYPERTENSIONAHA.107.091355Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an α-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54–61. PMID: 17515447. doi:10.1161/HYPERTENSIONAHA.107.091355

The authors declare that there are no conflicts of interest present.